Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 10.2 % in the past year, substantial increase in net sales/revenue by 0.48 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 244.44 %. Marginal increase in other income during this quarter, up by 193.94%.
- Profit over the Year and quarter: Significant improvement in profitability for Torrent Pharmaceuticals Ltd.. Notable increase of 56.45 % in net profit Year to Year, Torrent Pharmaceuticals Ltd.’s profitability increased by 1.35 % in this quarter.
- EPS over the Year and quarter: EPS increased by 56.49 % Year to Year. EPS increased by 1.3 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 2491 Cr | Rs. 2732 Cr | Rs. 2745 Cr | + 0.48 % | + 10.2 % |
| Expenses | Rs. 1764 Cr | Rs. 1863 Cr | Rs. 1862 Cr | -0.05 % | + 5.56 % |
| Operating Profit | Rs. 727 Cr | Rs. 869 Cr | Rs. 883 Cr | + 1.61 % | + 21.46 % |
| OPM % | 29.19 % | 31.81 % | 32.17 % | + 0.36 % | + 2.98 % |
| Other Income | Rs. 9 Cr | Rs. -33 Cr | Rs. 31 Cr | + 193.94 % | + 244.44 % |
| Interest | Rs. 107 Cr | Rs. 80 Cr | Rs. 80 Cr | + 0 % | -25.23 % |
| Depreciation | Rs. 196 Cr | Rs. 213 Cr | Rs. 203 Cr | -4.69 % | + 3.57 % |
| Profit before tax | Rs. 433 Cr | Rs. 543 Cr | Rs. 631 Cr | + 16.21 % | + 45.73 % |
| Tax % | 33.72 % | 29.79 % | 28.84 % | -0.95 % | -4.88 % |
| Net Profit | Rs. 287 Cr | Rs. 443 Cr | Rs. 449 Cr | + 1.35 % | + 56.45 % |
| EPS in Rs | Rs. 8.48 | Rs. 13.1 | Rs. 13.27 | + 1.3 % | + 56.49 % |
Today, we’re looking at Torrent Pharmaceuticals Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 10.2 %. However, it did see a marginal increase of 0.48 % from the previous quarter. Expenses decreased slightly by -0.05 % quarter-on-quarter, aligning with the annual rise of 5.56 %. Operating profit, while up 21.46 % compared to last year, faced a quarter-on-quarter increase of 1.61 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.98 %, but an expansion of 0.36 % sequentially. Other income rose by 193.94 % compared to the last quarter, despite an annual growth of 244.44 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year decrease remains at a moderate -25.23 %. Depreciation costs fell by -4.69 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 3.57 %. Profit before tax grew annually by 45.73 % but saw an increase from the preceding quarter by 16.21 %.
Tax expenses as a percentage of profits decreased slightly by -4.88 % compared to last year, with a more notable quarter-on-quarter decrease of -0.95 %. Net profit rose by 56.45 % year-on-year but experienced a 1.35 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 56.49 % but a quarterly rise of 1.3 %. In summary, Torrent Pharmaceuticals Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 2491 Cr | Rs. 2732 Cr | Rs. 2745 Cr | + 0.48 % | + 10.2 % |
| Expenses | Rs. 1764 Cr | Rs. 1863 Cr | Rs. 1862 Cr | -0.05 % | + 5.56 % |
| Operating Profit | Rs. 727 Cr | Rs. 869 Cr | Rs. 883 Cr | + 1.61 % | + 21.46 % |
| Net Profit | Rs. 287 Cr | Rs. 443 Cr | Rs. 449 Cr | + 1.35 % | + 56.45 % |
| EPS in Rs | Rs. 8.48 | Rs. 13.1 | Rs. 13.27 | + 1.3 % | + 56.49 % |
In reviewing Torrent Pharmaceuticals Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 10.2 % year-on-year growth, however, there was a minor increase of 0.48 % from the previous quarter. Expenses rose by 5.56 % compared to the previous year, with a decrease of -0.05 % quarter-on-quarter. Operating Profit surged by 21.46 % annually, and saw a 1.61 % increase from the last quarter.
Net Profit showed yearly increase of 56.45 %, and experienced a 1.35 % increase from the previous quarter. Earnings Per Share (EPS) rose by 56.49 % annually, however rose by 1.3 % compared to the last quarter. In essence, while Torrent Pharmaceuticals Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
